Given these findings, it would be valuable to investigate whether paeoniflorin can downregulate the upstream biomarker Wnt/β-catenin in the context of retinal ischemia, along with associated downstream biomarkers such as HIF-1α and VEGF, as well as the pro-inflammatory/angiogenic marker Ang-2. The gene discussed is VEGFA; the disease is retinal ischemia.